Ensysce Biosciences (ENSC) Free Cash Flow (2017 - 2026)
Ensysce Biosciences (ENSC) free cash flow from Sep 30, 2017 to Mar 31, 2026. The TTM Ensysce Biosciences (ENSC) free cash flow is -$9.73M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Ensysce Biosciences (ENSC) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +67.76% |
| 3 Years TTM | -18.63% |
| 5 Years TTM | +60.98% |
| All Time TTM | +40.01% |
Annual Free Cash Flow change of Ensysce Biosciences (ENSC)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$3.50M | -55.86% |
| 2025 | -$7.93M | +5.73% |
| 2024 | -$7.50M | -30.43% |
| 2023 | -$11M | -39.74% |
| 2022 | -$18M | +117.11% |
| 2021 | -$8.24M | +858.14% |
| 2020 | -$860K | -39.44% |
| 2019 | -$1.42M | +14.52% |
| 2018 | -$1.24M | +396.00% |
| 2017 | -$250K | N/A |
Comparison Ensysce Biosciences (ENSC) five years free cash flow CAGR with competitors
Ensysce Biosciences (ENSC) five years free cash flow CAGR is 61.09%.